Companies: 10,795·Total market cap: $144.5T
Cellectis S.A.

Cellectis S.A.

CLLSNASDAQHealthcare● Active
$2.99
$-0.07(-2.29%)
Market Cap$300247165
P/E Ratio
52W High$5.48
52W Low$1.327

Cellectis S.A.(CLLS)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · CLLS · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$72.95M$41.51M$0.76M$19.17M$30.35M
Cost of Revenue$9.80M$9.18M$7.42M$8.48M$1.84M
Gross Profit$63.15M$32.32M($6.66M)$10.69M$28.50M
Gross Margin %(computed)86.57%77.88%-882.65%55.75%93.92%
Operating Expenses
R&D Expenses$93.52M$90.54M$87.65M$97.50M$117.84M
G&A Expenses$8.60M$8.42M$8.12M$8.89M$37.87M
Total Operating Expenses$96.23M$91.88M$90.64M$100.35M$131.98M
Operating Income($33.08M)($59.55M)($97.30M)($89.67M)($103.48M)
Operating Margin %(computed)-45.34%-143.48%-467.72%-341.00%
Interest Income$9.50M$11.28M$3.61M$1.12M$0.72M
Interest Expense$8.11M$7.45M$5.31M$3.79M$4.37M
Income Before Tax($68.02M)($36.76M)($116.46M)($98.60M)($96.75M)
Income Tax Expense($0.42M)$0.00M$0.37M$0.09M($0.00M)
Net Income($67.59M)($36.76M)($101.06M)($106.14M)($114.20M)
Net Margin %(computed)-92.66%-88.57%-553.64%-376.32%
Per Share & EBITDA
EPS (Basic)$-0.68$-0.41$-1.77$-2.33$-1.93
Wtd Avg Shares100.28M90.57M57.01M45.55M44.82M
EBITDA($39.85M)($9.46M)($92.64M)($76.38M)($78.42M)
EBITDA Margin %(computed)-54.62%-22.80%-398.40%-258.44%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解Cellectis S.A.

关于Cellectis S.A.(CLLS)损益表

Cellectis S.A.(CLLS)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,CLLS实现营收$0.07B,毛利润$0.06B(毛利率86.57%),净利润($0.07B)(净利率-92.66%)。

常见问题

CLLS · 4 问

Cellectis S.A.(CLLS)2025财年营收为$0.07B,同比up75.8%。

CLLS revenueCLLS salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08